← Open Payments lookup

JUAN SILVA: Open Payments

NPI 1790738110 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,413 in 50 payments from 20 companies in 2025. Trend: 2023 $1,452 · 2024 $1,548 · 2025 $1,413

Food & beverage: $1,413
CompanyPaymentsAmount
Abbott Laboratories6$250
ABBVIE INC.8$213
Boston Scientific Corporation1$156
Novo Nordisk Inc6$126
Lilly USA, LLC4$115
Merck Sharp & Dohme LLC4$96
Boehringer Ingelheim Pharmaceuticals, Inc.4$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$61
Corcept Therapeutics2$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42

Products named: FREESTYLE LIBRE 3, WATCHMAN FLX, VRAYLAR, MOUNJARO, JARDIANCE, Ozempic, CAPLYTA, CREON.

Industry payments across CA — which companies pay providers there.